The 60s brought new paths for diagnosis and treatment in Portugal, with significant advances in Portuguese biomedical research. The works distinguished by the Pfizer Awards followed some of these progresses, from the so-called "foot disease" to nuclear medicine.
The Pfizer Awards project celebrates seven decades of partnership between the pharmaceutical company and the Society of Medical Sciences of Lisbon. This long-standing collaboration has been distinguishing biomedical research work in Portugal over the decades.
Expresso is again associating with the project as a media partner, making available this series of articles that take a journey through the 70-year history of this initiative.
This publication corresponds to the second episode of this series that documents the evolution of Portuguese biomedical research, showing how the Pfizer Awards have followed the main scientific advances in the country.
